Oral Anticoagulation, AF, and Recurrent Stroke Risk: New Data

  • 📰 Medscape
  • ⏱ Reading Time:
  • 27 sec. here
  • 26 min. at publisher
  • 📊 Quality Score:
  • News: 98%
  • Publisher: 55%

Atrial Fibrillation News

AF,Afib,A-Fib

Despite secondary prevention with OAC, the risk for recurrent stroke and mortality is high in patients with AF. However, OAC discontinuation is tied to a doubling of recurrent stroke.

. However, OAC discontinuation doubled the risk for recurrent IS compared with those who continued on blood thinners, new research showed.

While previous studies have examined this increased risk prior to the index IS, few have specifically focused on OAC discontinuation and the risk for IS recurrence.

At 1 year, the crude cumulative incidence of recurrent IS and all-cause mortality were 4.3% and 15.4% , respectively. The researchers found similar results in the adjusted analyses." There was no information about the reasons patients discontinued OAC."Reasons underpinning OAC discontinuation are at present poorly understood," they wrote.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in HEALTH

Health Health Latest News, Health Health Headlines